✦ LIBER ✦

Clinical implications of autonomic drugs

✍ Scribed by Becker, Daniel E.

Book ID: 122527220
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 882 KB
Volume: 50
Category: Article
ISSN: 1531-5053
DOI: 10.1016/0278-2391(92)90109-D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

79-CLINICAL PERTINENCE OF DRUG INDUCED A

79-CLINICAL PERTINENCE OF DRUG INDUCED AUTONOMIC DYSFUNCTION

✍ M Mueck-Weymann; K Poehlmann; M Siepmann; M Agelink; P Joraschky 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 16 KB

Clinical implications of drug metabolism

Clinical implications of drug metabolism — introduction

✍ Daniel L. Azarnoff 📂 Article 📅 1971 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Clinical implications of urinary drug sc

Clinical implications of urinary drug screens

✍ Michael F. Barber 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 442 KB

Clinical Implications of Drug Abuse Epid

Clinical Implications of Drug Abuse Epidemiology

✍ Schulden, Jeffrey D.; Lopez, Marsha F.; Compton, Wilson M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Clinical Implications of Drug Interactio

Clinical Implications of Drug Interactions with Coxibs

✍ William R. Garnett 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Pharmacokinetics of long-acting injectab

Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications

✍ Stephen R. Marder; John W. Hubbard; Theodore Putten; Kamal K. Midha 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 937 KB

The authors review the literature regarding the pharmacokinetics of long-acting injectable neuroleptic drugs (LINS). There are important differences between LINS and oral neuroleptics that affect their pharmacokinetics. By avoiding first pass metabolism in gut and liver, LINS result in lower circula